JP2023140651A - Bowel movement improving composition, method for producing bowel movement improving composition, and method for improving bowel movement - Google Patents
Bowel movement improving composition, method for producing bowel movement improving composition, and method for improving bowel movement Download PDFInfo
- Publication number
- JP2023140651A JP2023140651A JP2022046599A JP2022046599A JP2023140651A JP 2023140651 A JP2023140651 A JP 2023140651A JP 2022046599 A JP2022046599 A JP 2022046599A JP 2022046599 A JP2022046599 A JP 2022046599A JP 2023140651 A JP2023140651 A JP 2023140651A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- bowel movement
- improving
- resorcinol
- improving bowel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000033001 locomotion Effects 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims abstract description 8
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims abstract description 35
- 229930188104 Alkylresorcinol Natural products 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 19
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- -1 resorcinol lipid Chemical class 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 241000196324 Embryophyta Species 0.000 claims description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- 241000209140 Triticum Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 6
- 241000209504 Poaceae Species 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 235000014593 oils and fats Nutrition 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 235000020985 whole grains Nutrition 0.000 claims description 3
- 235000015099 wheat brans Nutrition 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 14
- 125000000217 alkyl group Chemical group 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 10
- IRMPFYJSHJGOPE-UHFFFAOYSA-N olivetol Chemical compound CCCCCC1=CC(O)=CC(O)=C1 IRMPFYJSHJGOPE-UHFFFAOYSA-N 0.000 description 10
- 230000013872 defecation Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000000469 ethanolic extract Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- PUNOCEUUYUXUGR-UHFFFAOYSA-N 5-Nonadecyl-1,3-benzenediol Chemical compound CCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 PUNOCEUUYUXUGR-UHFFFAOYSA-N 0.000 description 3
- BBGNINPPDHJETF-UHFFFAOYSA-N 5-heptadecylresorcinol Chemical compound CCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 BBGNINPPDHJETF-UHFFFAOYSA-N 0.000 description 3
- QENPJKGENOZEEJ-UHFFFAOYSA-N 5-heptylbenzene-1,3-diol Chemical compound CCCCCCCC1=CC(O)=CC(O)=C1 QENPJKGENOZEEJ-UHFFFAOYSA-N 0.000 description 3
- OYXWBGYHDYVIDT-UHFFFAOYSA-N 5-nonylbenzene-1,3-diol Chemical compound CCCCCCCCCC1=CC(O)=CC(O)=C1 OYXWBGYHDYVIDT-UHFFFAOYSA-N 0.000 description 3
- SXRLJXDYAKBNRZ-UHFFFAOYSA-N 5-undecylbenzene-1,3-diol Chemical compound CCCCCCCCCCCC1=CC(O)=CC(O)=C1 SXRLJXDYAKBNRZ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UXOGOSLLGMYCNL-UHFFFAOYSA-N Grevillol Chemical compound CCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 UXOGOSLLGMYCNL-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KVVSCMOUFCNCGX-UHFFFAOYSA-N cardol Chemical compound CCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 KVVSCMOUFCNCGX-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 2
- BLHLKJLSYHEOGY-UHFFFAOYSA-N 5-Heneicosyl-1,3-benzenediol Chemical compound CCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 BLHLKJLSYHEOGY-UHFFFAOYSA-N 0.000 description 2
- GDJMJAKVVSGNLA-UHFFFAOYSA-N 5-Pentacosyl-1,3-benzenediol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 GDJMJAKVVSGNLA-UHFFFAOYSA-N 0.000 description 2
- LNHZINSBVLHRFL-UHFFFAOYSA-N 5-heptacosylbenzene-1,3-diol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 LNHZINSBVLHRFL-UHFFFAOYSA-N 0.000 description 2
- OHTBGMREZYLZQD-UHFFFAOYSA-N 5-tricosylresorcinol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 OHTBGMREZYLZQD-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001113425 Iridaceae Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000012675 alcoholic extract Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 description 1
- 239000004101 4-Hexylresorcinol Substances 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- 235000019360 4-hexylresorcinol Nutrition 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 241000208465 Proteaceae Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000010006 flight Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940106025 phenylethyl resorcinol Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Landscapes
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は、便通改善用組成物、便通改善用組成物の製造方法、及び便通を改善する方法に関する。 The present invention relates to a composition for improving bowel movements, a method for producing a composition for improving bowel movements, and a method for improving bowel movements.
近年、健康意識の高まりから、食物繊維、ビタミン、ミネラル等の栄養素に富む小麦、ライ麦等の穀物の有効利用が検討されている。穀物には、アルキルレゾルシノール性脂質が含まれている。アルキルレゾルシノール性脂質はイネ科の穀物、ナッツ類の種皮から抽出されたり、合成されたりする化合物であり、レゾルシノール(1,3-ジヒドロキシベンゼン)の芳香環の2位、4位、5位、及び6位の少なくとも1つにアルキル基を有している。アルキルレゾルシノール性脂質は口腔用抗菌、免疫抑制、抗糖尿病、抗炎症、腸内フローラ調整、抗コレステロール、抗肥満、睡眠改善、老化抑制、概日リズム調整等の人に対する作用を有することが報告されている。特許文献1には、アルキルレゾルシノールは小麦外皮のアリューロン層に近い部位に局在していることが記載されている。 In recent years, as health consciousness has increased, consideration has been given to the effective use of grains such as wheat and rye, which are rich in nutrients such as dietary fiber, vitamins, and minerals. Cereals contain alkylresorcinol lipids. Alkylresorcinol lipids are compounds that are extracted from the seed coats of grasses and nuts, and are compounds that are synthesized from the 2nd, 4th, 5th, and 4th positions of the aromatic ring of resorcinol (1,3-dihydroxybenzene). It has an alkyl group in at least one of the 6-positions. Alkylresorcinol lipids have been reported to have effects on humans such as oral antibacterial, immunosuppressive, antidiabetic, anti-inflammatory, intestinal flora regulation, anticholesterol, antiobesity, sleep improvement, anti-aging, and circadian rhythm regulation. ing. Patent Document 1 describes that alkylresorcinol is localized in a region close to the aleurone layer of the wheat husk.
一方、特許文献2には、イネ科植物のアルコール抽出物はアルキルレゾルシノールを有効成分として含有し、当該アルコール抽出物を2か月以上マウスに摂取させると腸内フローラ調整能が確認されることが記載されている。 On the other hand, Patent Document 2 states that an alcoholic extract of a grass family plant contains alkylresorcinol as an active ingredient, and that when the alcoholic extract is ingested by mice for two months or more, the ability to adjust intestinal flora is confirmed. Are listed.
近年、植物由来のレゾルシノール性脂質の上記される人に対する作用以外の新たな作用を発見し、当該新たな作用を利用した組成物が希求されていたが、そのような組成物は提供されていなかった。本発明が解決しようとする課題は、当該新たな作用を利用した組成物、及び当該組成物の製造方法を提供することである。 In recent years, a new effect of plant-derived resorcinol lipids other than the above-mentioned effect on humans has been discovered, and a composition that utilizes this new effect has been desired, but such a composition has not been provided. Ta. The problem to be solved by the present invention is to provide a composition that utilizes the new effect and a method for producing the composition.
本発明者らは上記課題に鑑み検討を重ね、植物由来のレゾルシノール性脂質が便通改善作用を有することを見出した。本発明はこれらの知見に基づき完成されるに至ったものである。
なお、腸内フローラが調整されても便通が改善されるわけではない。
The present inventors have conducted repeated studies in view of the above-mentioned problems, and have discovered that plant-derived resorcinol lipids have a bowel movement improving effect. The present invention has been completed based on these findings.
Note that adjusting intestinal flora does not necessarily improve bowel movements.
本発明は、植物由来のレゾルシノール性脂質を含む便通改善用組成物である。
前記レゾルシノール性脂質は、好ましくはアルキルレゾルシノールを含む。
前記レゾルシノール性脂質は、好ましくはイネ科植物由来である。
前記レゾルシノール性脂質は、より好ましくは小麦ふすま、ライ麦ふすま、小麦全穀粒、及びライ麦全穀粒の少なくとも1つの由来である。
本発明の便通改善用組成物は、好ましくは飲食品、食品添加物、医薬品、サプリメント、及び動物飼料の少なくとも1つとして提供される。
本発明の便通改善用組成物の製造方法は、レゾルシノール性脂質を含有する植物から溶媒で前記レゾルシノール性脂質を抽出する工程を含む。
前記溶媒は、好ましくは油脂、アルコール類、エーテル類、エステル類、ケトン類、ヘキサン、及びクロロホルムの少なくとも1つである。
前記溶媒は、好ましくはエタノール及び/又はヘキサンである。
本発明の便通を改善する方法は、本発明の便通改善用組成物を、動物に摂取させる工程を含む。
The present invention is a composition for improving bowel movement containing a plant-derived resorcinol lipid.
The resorcinol lipid preferably includes an alkylresorcinol.
The resorcinol lipid is preferably derived from a plant belonging to the Poaceae family.
The resorcinol lipid is more preferably derived from at least one of wheat bran, rye bran, whole wheat grain, and whole rye grain.
The composition for improving bowel movements of the present invention is preferably provided as at least one of food and drink products, food additives, pharmaceuticals, supplements, and animal feed.
The method for producing a composition for improving bowel movements of the present invention includes the step of extracting resorcinol lipids from a plant containing the resorcinol lipids using a solvent.
The solvent is preferably at least one of oils and fats, alcohols, ethers, esters, ketones, hexane, and chloroform.
The solvent is preferably ethanol and/or hexane.
The method for improving bowel movements of the present invention includes the step of causing an animal to ingest the composition for improving bowel movements of the present invention.
本発明は、植物由来のレゾルシノール性脂質の新たに発見された便通改善作用を利用した組成物、当該組成物の製造方法、及び便通を改善する方法を提供できる。 The present invention can provide a composition that utilizes the newly discovered defecation-improving effect of plant-derived resorcinol lipids, a method for producing the composition, and a method for improving defecation.
本発明について更に詳細に説明する。
[便通改善用組成物]
<便通改善>
本発明における便通改善とは、後述する動物が本発明の便通改善用組成物を摂取した場合、後述する動物が本発明の便通改善用組成物を摂取しなかった場合に比べ、単位時間当たりの便通回数が増加し、かつ便の性状も健康時の便の性状に近づくことを意味する。
The present invention will be explained in more detail.
[Composition for improving bowel movements]
<Improvement of bowel movement>
Defecation improvement in the present invention means that when an animal described later ingests the composition for improving defecation of the present invention, compared to when the animal described below does not ingest the composition for improving defecation of the present invention. This means that the frequency of bowel movements increases and the quality of the stool approaches that of healthy stool.
<植物由来のレゾルシノール性脂質>
本発明の便通改善用組成物は植物由来のレゾルシノール性脂質を含む。上述したとおり、レゾルシノール性脂質は、レゾルシノール(1,3-ジヒドロキシベンゼン)の芳香環の2位、4位、5位、及び/又は6位にアルキル基を有してなる親油性物質である。天然には、ウルシ科、イチョウ科、ヤマモガシ科、ヤブコウジ科、サクラソウ科、ニクズク科、アヤメ科、サトイモ科、マメ科、イネ科等に属する植物、キク科のヨモギなどに多くみられる。これらの植物のなかでも、小麦、ライ麦等のイネ科植物には、その可食部(種子)にレゾルシノール性脂質が比較的豊富に含まれているため、本発明に用いるレゾルシノール性脂質の原料体として好適に用いられ得る。例えば、小麦、ライ麦等の可食部(種子)の糟糠類や全穀粒中には、下記式(I)に示すアルキルレゾルシノール化合物が0.015~0.3質量%程度含まれている。なお、小麦やライ麦を原料とする味噌等発酵物なども、本発明に用いるレゾルシノール性脂質の好ましい原料体として例示し得る。
前記レゾルシノール性脂質として、例えば4-ブチルレゾルシノール(ルシノール)、4-ヘキシルレゾルシノール、フェニルエチルレゾルシノール、1-(2,4-ジヒドロキシフェニル)-3-(2,4-ジメトキシ-3-メチルフェニル)-プロパン等のアルキルレゾルシノールが挙げられる。
<Plant-derived resorcinol lipids>
The composition for improving bowel movements of the present invention contains a plant-derived resorcinol lipid. As mentioned above, resorcinol lipids are lipophilic substances having alkyl groups at the 2-position, 4-position, 5-position, and/or 6-position of the aromatic ring of resorcinol (1,3-dihydroxybenzene). In nature, it is often found in plants belonging to the Anacardiaceae, Ginkgoaceae, Proteaceae, Arboraceae, Primulaceae, Iridaceae, Iridaceae, Araceae, Fabaceae, Poaceae, etc., and mugwort of the Asteraceae. Among these plants, gramineous plants such as wheat and rye contain relatively abundant resorcinol lipids in their edible parts (seeds), so they can be used as raw materials for the resorcinol lipids used in the present invention. It can be suitably used as For example, the bran and whole grains of edible parts (seeds) of wheat, rye, etc. contain about 0.015 to 0.3% by mass of an alkylresorcinol compound represented by the following formula (I). In addition, fermented products such as miso made from wheat or rye can also be exemplified as preferred raw materials for the resorcinol lipid used in the present invention.
Examples of the resorcinol lipids include 4-butylresorcinol (Rucinol), 4-hexylresorcinol, phenylethylresorcinol, 1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)- Examples include alkylresorcinols such as propane.
本発明に用いるレゾルシノール性脂質としては、典型的には、下記式(I)で表されるアルキルレゾルシノール化合物が挙げられる。 The resorcinol lipid used in the present invention typically includes an alkylresorcinol compound represented by the following formula (I).
式(I)中、R1は、飽和又は不飽和の直鎖又は分岐鎖アルキル基を表す。R1で表されるアルキル基の炭素数は、制限されるものではないが、好ましくは1~237、より好ましくは3~27、更に好ましくは5~27である。 In formula (I), R1 represents a saturated or unsaturated linear or branched alkyl group. The number of carbon atoms in the alkyl group represented by R1 is not limited, but is preferably 1 to 237, more preferably 3 to 27, even more preferably 5 to 27.
式(I)中、R1は、好ましくは飽和又は不飽和の直鎖アルキル基であり、より好ましくは飽和直鎖アルキル基である。R1で表される飽和直鎖アルキル基の例としては、メチル、n-プロピル、n-ペンチル、n-ヘプチル、n-ノニル、n-ウンデシル、n-トリデシル、n-ペンタデシル、n-ヘプタデシル、n-ノナデシル、n-ヘンイコシル、n-トリコシルなどが挙げられる。 In formula (I), R1 is preferably a saturated or unsaturated straight chain alkyl group, more preferably a saturated straight chain alkyl group. Examples of the saturated straight-chain alkyl group represented by R1 include methyl, n-propyl, n-pentyl, n-heptyl, n-nonyl, n-undecyl, n-tridecyl, n-pentadecyl, n-heptadecyl, n- -nonadecyl, n-henicosyl, n-tricosyl, etc.
式(I)中、R1で表される不飽和直鎖アルキル基の不飽和結合の位置や数は、特に制限されない。当該不飽和直鎖アルキル基の例としては、上述した飽和直鎖アルキル基の炭素鎖上の任意の位置に不飽和結合を有するアルキル基が挙げられる。
式(I)中、R1で表される飽和又は不飽和の分岐鎖アルキル基の分岐の位置と数、不飽和結合の位置と数は、特に制限されない。
In formula (I), the position and number of unsaturated bonds in the unsaturated straight chain alkyl group represented by R1 are not particularly limited. Examples of the unsaturated straight-chain alkyl group include the above-mentioned saturated straight-chain alkyl group having an unsaturated bond at any position on the carbon chain.
In formula (I), the position and number of branches of the saturated or unsaturated branched alkyl group represented by R1 and the position and number of unsaturated bonds are not particularly limited.
上記式(I)化合物の好ましい例としては、以下が挙げられる。
5-ペンチルレゾルシノール[オリベトール、又は1,3-ジヒドロキシ-5-n-ペンチルベンゼン(C5:0)]
5-ヘプチルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ヘプチルベンゼン(C7:0)]
5-ノニルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ノニルベンゼン(C9:0)]
5-ウンデシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ウンデシルベンゼン(C11:0)]
5-トリデシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-トリデシルベンゼン(C13:0)]
5-ペンタデシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ペンタデシルベンゼン(C15:0)]
5-ヘプタデシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ヘプタデシルベンゼン(C17:0)]
5-ノナデシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ノナデシルベンゼン(C19:0)]
5-ヘンイコシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ヘンイコシルベンゼン(C21:0)]
5-トリコシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-トリコシルベンゼン(C23:0)]
5-ペンタコシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ペンタコシルベンゼン(C25:0)]
5-ヘプタコシルレゾルシノール[又は1,3-ジヒドロキシ-5-n-ヘプタコシルベンゼン(C27:0)]
Preferred examples of the compound of formula (I) include the following.
5-pentylresorcinol [olivetol or 1,3-dihydroxy-5-n-pentylbenzene (C5:0)]
5-heptylresorcinol [or 1,3-dihydroxy-5-n-heptylbenzene (C7:0)]
5-nonylresorcinol [or 1,3-dihydroxy-5-n-nonylbenzene (C9:0)]
5-Undecylresorcinol [or 1,3-dihydroxy-5-n-undecylbenzene (C11:0)]
5-Tridecylresorcinol [or 1,3-dihydroxy-5-n-tridecylbenzene (C13:0)]
5-pentadecylresorcinol [or 1,3-dihydroxy-5-n-pentadecylbenzene (C15:0)]
5-heptadecylresorcinol [or 1,3-dihydroxy-5-n-heptadecylbenzene (C17:0)]
5-nonadecylresorcinol [or 1,3-dihydroxy-5-n-nonadecylbenzene (C19:0)]
5-henicosylresorcinol [or 1,3-dihydroxy-5-n-henicosylbenzene (C21:0)]
5-tricosylresorcinol [or 1,3-dihydroxy-5-n-tricosylbenzene (C23:0)]
5-pentacosylresorcinol [or 1,3-dihydroxy-5-n-pentacosylbenzene (C25:0)]
5-heptacosylresorcinol [or 1,3-dihydroxy-5-n-heptacosylbenzene (C27:0)]
<便通改善用組成物の形態>
本発明の便通改善用組成物は、粉末等の固体、ゲル化剤によりゲル化されたゲル状体、又は溶媒に溶解している液状体であってよい。さらに、本発明の便通改善用組成物は、錠剤(口腔内側崩壊錠、咀嚼可能錠、発泡錠、トローチ剤、ゼリー状ドロップ剤等)、丸剤、顆粒剤、細粒剤、散剤、硬カプセル剤、軟カプセル剤、ドライシロップ剤、液剤(懸濁剤、シロップ剤等)、ゼリー剤等の便通改善剤として提供されてよい。すなわち、各形態の一部として、上記の植物由来のレゾルシノール性油脂を含有せしめることによって、摂取し易い形態となすことができる。
<Form of composition for improving bowel movements>
The composition for improving bowel movements of the present invention may be a solid such as a powder, a gel-like body gelled with a gelling agent, or a liquid body dissolved in a solvent. Furthermore, the composition for improving bowel movement of the present invention can be used in tablets (orally disintegrating tablets, chewable tablets, effervescent tablets, troches, jelly drops, etc.), pills, granules, fine granules, powders, and hard capsules. It may be provided as a bowel movement improving agent such as a tablet, soft capsule, dry syrup, liquid (suspension, syrup, etc.), or jelly. That is, by containing the above-mentioned plant-derived resorcinol fats and oils as a part of each form, it is possible to make it into a form that is easy to ingest.
一方、本発明による肝臓機能改善用組成物は、上記の植物由来のレゾルシノール性油脂から実質的に構成されていてもよい。よって、例えば任意の形態中のレゾルシノール性油脂の含有量は、好ましくは0.1質量%以上の範囲であり、より好ましくは0.5質量%以上の範囲であり、更に好ましくは1.0質量%以上の範囲である。また、当該含有量は、好ましくは100質量%以下の範囲であり、より好ましくは90質量%以下の範囲であり、更に好ましくは80質量%以下の範囲である。 On the other hand, the composition for improving liver function according to the present invention may be substantially composed of the above-mentioned plant-derived resorcinol fats and oils. Therefore, for example, the content of resorcinol fat in any form is preferably 0.1% by mass or more, more preferably 0.5% by mass or more, and still more preferably 1.0% by mass. % or more. Further, the content is preferably in a range of 100% by mass or less, more preferably in a range of 90% by mass or less, and even more preferably in a range of 80% by mass or less.
<他の成分>
本発明の便通改善用組成物は、前記用途に使用される他の成分を含んでいてもよい。他の成分として、例えば基剤、担体、溶剤、分散剤、乳化剤、緩衝剤、安定剤、賦形剤、結合剤、崩壊剤、滑沢剤、増粘剤、着色料、香料、キレート剤、各種ビタミン類、ミネラル類、生薬等が挙げられる。
<Other ingredients>
The composition for improving bowel movements of the present invention may contain other components used for the above-mentioned purposes. Other ingredients include, for example, bases, carriers, solvents, dispersants, emulsifiers, buffers, stabilizers, excipients, binders, disintegrants, lubricants, thickeners, colorants, fragrances, chelating agents, Examples include various vitamins, minerals, and crude drugs.
<便通改善用組成物の用途>
本発明の便通改善用組成物は、便秘改善用の、飲食品、食品添加物、医薬品、サプリメント、及び動物飼料の少なくとも1つとして提供することができる。
典型的な飲食品の形態としては、緑茶、ウーロン茶、紅茶等の茶飲料、コーヒー飲料、清涼飲料、ゼリー飲料、スポーツ飲料、乳飲料、炭酸飲料、果汁飲料、乳酸菌飲料、発酵乳飲料、粉末飲料、ココア飲料、アルコール飲料、ミネラルウォーター等の飲料、バター、ジャム、ふりかけ、マーガリン等のスプレッド類、マヨネーズ、ショートニング、クリーム、ドレッシング類、パン類、米飯類、麺類、パスタ、味噌汁、豆腐、牛乳、ヨーグルト、スープ、ソース類、菓子(例えばビスケット、クッキー類、チョコレート、キャンディ、ケーキ、アイスクリーム、チューインガム、タブレット)等が挙げられる。
<Applications of the composition for improving bowel movements>
The composition for improving bowel movements of the present invention can be provided as at least one of foods and drinks, food additives, pharmaceuticals, supplements, and animal feed for improving constipation.
Typical food and drink forms include tea drinks such as green tea, oolong tea, and black tea, coffee drinks, soft drinks, jelly drinks, sports drinks, milk drinks, carbonated drinks, fruit juice drinks, lactic acid bacteria drinks, fermented milk drinks, and powdered drinks. , cocoa drinks, alcoholic drinks, drinks such as mineral water, spreads such as butter, jam, furikake, margarine, mayonnaise, shortening, cream, dressings, bread, rice, noodles, pasta, miso soup, tofu, milk, Examples include yogurt, soup, sauces, confectionery (eg, biscuits, cookies, chocolate, candy, cake, ice cream, chewing gum, tablets), and the like.
[便通改善用組成物の製造方法]
本発明に用いる植物由来のレゾルシノール性脂質は、例えば市販品を入手して用いてもよく、あるいは植物から常法により抽出して用いてもよい。例えば、上記式(I)化合物の市販品を、ReseaChem GmbH社、SIGMA-ALDRICH社等から購入できる。
本発明に用いる植物由来のレゾルシノール性脂質を、植物から抽出してもよい。植物からの当該抽出方法としては、上記原料体を、常圧又は加圧下で室温又は加温した抽出溶媒中に必要に応じて撹拌しながら浸漬させる方法、還流抽出法などが挙げられる。上記原料体は、抽出溶媒に添加される前に、必要に応じて切断、粉砕、圧搾、及び乾燥の少なくとも1つの処理に付されてもよい。
[Method for producing a composition for improving bowel movements]
The plant-derived resorcinol lipid used in the present invention may be used, for example, as a commercially available product, or may be extracted from plants by a conventional method. For example, the above-mentioned compound of formula (I) can be purchased commercially from ReseaChem GmbH, SIGMA-ALDRICH, and the like.
The plant-derived resorcinol lipid used in the present invention may be extracted from plants. Examples of the extraction method from plants include a method in which the raw material is immersed in an extraction solvent at room temperature or at a temperature under normal pressure or pressure, with stirring as necessary, a reflux extraction method, and the like. The raw material may be subjected to at least one of cutting, crushing, squeezing, and drying as necessary before being added to the extraction solvent.
<レゾルシノール性脂質の抽出溶媒>
本発明で使用される前記溶媒として、
メタノール、エタノール、n-プロパノール、イソプロパノール、n-ブタノール等の低級アルコール、1,3-ブチレングリコール、プロピレングリコール、グリセリン等の多価アルコール等のアルコール類、
ジエチルエーテル、プロピルエーテル等のエーテル類、
酢酸ブチル、酢酸エチル等のエステル類、
アセトン、メチルエチルケトン等のケトン類、
油脂、ヘキサン、クロロホルム等の有機溶媒が挙げられる。これらの有機溶媒の1種又は2種以上が使用される。上記溶媒のうち、操作性、環境に対する影響などの点から、室温で液体であるアルコール類、例えば炭素原子数1~4の低級アルコールが好ましく、残留溶媒による安全性の観点からはエタノールがより好ましい。
<Extraction solvent for resorcinol lipids>
As the solvent used in the present invention,
Alcohols such as lower alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, and glycerin;
Ethers such as diethyl ether and propyl ether,
Esters such as butyl acetate and ethyl acetate,
Ketones such as acetone and methyl ethyl ketone,
Examples include organic solvents such as fats and oils, hexane, and chloroform. One or more of these organic solvents may be used. Among the above solvents, alcohols that are liquid at room temperature, such as lower alcohols having 1 to 4 carbon atoms, are preferred from the viewpoint of operability and environmental impact, and ethanol is more preferred from the viewpoint of safety due to residual solvent. .
前記油脂として、中鎖脂肪酸(MCT)オイル、サラダ油、パーム油、パームオレイン、パームステアリン、ラード、牛脂、乳脂肪、ヤシ油、パーム核油、なたね油、大豆油、コーン油、米油、綿実油、ひまわり油、ごま油、オリーブ油、それらの分別油、水素添加油、及びエステル交換油等、食品分野で通常使用される油脂が挙げられる。これらの油脂は、1種類を単独で用いてもよいし、2種類以上を混合して用いてもよい。 The fats and oils include medium chain fatty acid (MCT) oil, salad oil, palm oil, palm olein, palm stearin, lard, beef tallow, milk fat, coconut oil, palm kernel oil, rapeseed oil, soybean oil, corn oil, rice oil, cottonseed oil, Oils and fats commonly used in the food field include sunflower oil, sesame oil, olive oil, their fractionated oils, hydrogenated oils, and transesterified oils. These fats and oils may be used alone or in combination of two or more.
本発明で使用される抽出溶媒中の有機溶媒の総量に占める油脂、エタノール、及びヘキサンの少なくとも1種の割合は、好ましくは80質量%以上であり、より好ましくは90質量%以上であり、更に好ましくは100質量%である。 The proportion of at least one of oil, fat, ethanol, and hexane in the total amount of organic solvents in the extraction solvent used in the present invention is preferably 80% by mass or more, more preferably 90% by mass or more, and Preferably it is 100% by mass.
抽出溶媒としては、更に有機溶媒に水性成分が含まれている含水有機溶媒が挙げられる。抽出効率を高く保持する観点から、当該含水有機溶媒中の水性成分の含有量は、通常50体積%以下、好ましくは30体積%以下、より好ましくは20体積%以下である。含水有機溶媒としては、好ましくは上記のような室温で液体であるアルコール類に水性成分が含まれている含水アルコール、より好ましくは含水エタノールが挙げられる。 Examples of the extraction solvent include water-containing organic solvents in which the organic solvent further contains an aqueous component. From the viewpoint of maintaining high extraction efficiency, the content of the aqueous component in the water-containing organic solvent is usually 50% by volume or less, preferably 30% by volume or less, and more preferably 20% by volume or less. The water-containing organic solvent is preferably a water-containing alcohol in which an aqueous component is contained in an alcohol that is liquid at room temperature as described above, and more preferably water-containing ethanol.
抽出のための温度、時間等の条件は、使用する抽出溶媒の種類や抽出条件などによって適宜設定できるが、抽出温度は2~100℃、抽出時間は30分~60時間程度とするのが好ましい。抽出溶媒の量は、原料体100質量部に対し、好ましくは200~2000質量部程度にすればよい。また、抽出処理の後には、抽出液と残渣を含む混合物は、必要に応じて濾過又は遠心分離などに供し、残渣である固形成分を除去してもよい。さらに、除去した固形成分を再度、抽出溶媒を用いた抽出操作に供することもでき、この操作を何回か繰り返してもよい。得られた抽出物を、液体クロマトグラフィー等により、更に精製し、レゾルシノール性脂質を含む高純度の抽出物を調製してもよい。このように精製する場合、その精製度は、任意の形態中に、上記の植物由来のレゾルシノール性油脂の含有量として、好ましくは1質量%以上の範囲であり、より好ましくは3質量%以上の範囲であり、更に好ましくは5質量%以上の範囲である。
得られた抽出物を、そのまま、もしくは必要に応じて更に濃縮、凍結乾燥、熱風乾燥、粉砕、粉末化、分級、希釈、加水混合などの処理を施した後、本発明で用いる。
Conditions such as temperature and time for extraction can be set as appropriate depending on the type of extraction solvent used and extraction conditions, but it is preferable that the extraction temperature is 2 to 100°C and the extraction time is about 30 minutes to 60 hours. . The amount of extraction solvent may preferably be about 200 to 2,000 parts by mass based on 100 parts by mass of the raw material. Further, after the extraction process, the mixture containing the extract and the residue may be subjected to filtration or centrifugation, if necessary, to remove solid components that are the residue. Furthermore, the removed solid components can be subjected to an extraction operation using an extraction solvent again, and this operation may be repeated several times. The obtained extract may be further purified by liquid chromatography or the like to prepare a highly purified extract containing resorcinol lipids. When purified in this way, the degree of purification is such that the content of the above plant-derived resorcinol oil in any form is preferably 1% by mass or more, more preferably 3% by mass or more. The amount is more preferably 5% by mass or more.
The obtained extract is used in the present invention as it is, or after being further subjected to treatments such as concentration, freeze drying, hot air drying, pulverization, pulverization, classification, dilution, and mixing with water if necessary.
[便通を改善する方法]
本発明の便通を改善する方法は、前記便通改善用組成物を、動物に摂取させる工程を含む。当該「動物」は、人を含む動物であってもよく、人を除く動物であってもよい。本発明の便通改善用組成物の摂取により、排便回数が増加し、便性状も良好になる。本発明の便通改善用組成物の有効投与量(人を対象とした場合も含む)は、適用する個体の種、症状、年齢、性別などに応じて適宜変更され得る。人を対象とする場合の投与量は、通常、アルキルレゾルシノール換算で成人1人1日当たり0.01~10gである。当該1日投与量は、1回で投与されてもよいが、数回に分けて投与されてもよい。また、経口的に投与されることが、より好ましい。なお、適用対象は人に限られず、例えば、犬、猫等の動物用に適用することも可能である。
[How to improve bowel movements]
The method for improving bowel movements of the present invention includes the step of causing an animal to ingest the composition for improving bowel movements. The "animal" may be an animal including a human or an animal excluding a human. By ingesting the composition for improving bowel movement of the present invention, the frequency of defecation increases and the quality of the stool also improves. The effective dosage of the composition for improving bowel movements of the present invention (including when it is administered to humans) may be changed as appropriate depending on the species, symptoms, age, sex, etc. of the individual to whom it is applied. The dosage for humans is usually 0.01 to 10 g per adult per day in terms of alkylresorcinol. The daily dose may be administered once or divided into several doses. Moreover, it is more preferable to administer orally. Note that the application target is not limited to humans, but can also be applied to animals such as dogs and cats.
以下、本発明を実施例に基づき更に詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, the present invention will be explained in more detail based on Examples, but the present invention is not limited thereto.
[アルキルレゾルシノールの調製]
ライ麦ふすまに質量で5倍量の99質量%エタノールを添加して、室温下で500rpm、2時間撹拌抽出した。この抽出液を濾過して不要物を除きエタノール抽出液を回収した後、該抽出液からエタノールを留去し、ライ麦ふすまのエタノール抽出物を得た。
[Preparation of alkylresorcinol]
99% by weight ethanol was added to the rye bran in an amount 5 times the amount by weight, and the mixture was stirred and extracted at 500 rpm for 2 hours at room temperature. After filtering this extract to remove unnecessary substances and recovering an ethanol extract, ethanol was distilled off from the extract to obtain an ethanol extract of rye bran.
[アルキルレゾルシノールの高速液体クロマトグラフィーによる分析]
上記アルキルレゾルシノールの調製で得られた乾固物中のアルキルレゾルシノール量を高速液体クロマトグラフィーによる分析法で定量した。なお、以下、アルキルレゾルシノールのことを「ARs」又は「AR」という場合がある。
具体的には、分析カラムとしては、GL science社製Inertsil ODS4を使用し、分析条件としては、流速1mL/min、検出波長275nm、カラム温度40℃、移動相(89v/v%メタノール→(5分間)→92v/v%メタノール→(25分間)→100%メタノールのグラディエント)で実施した。アルキルレゾルシノールの標準品としては、市販のオリベトール(炭素数5の直鎖状のアルキル鎖を有するAR:シグマ・アルドリッチ)を用いた。オリベトールとはアルキル鎖長の異なる各ARの定量については、予め溶出位置は特定しておき、実測されたピーク面積について、それぞれの分子量をオリベトールの分子量で除した値を係数として、その係数で乗じることにより、換算した。
その結果、上記調製で得られたエタノール抽出物は、その1g中に35mgのARsが含有していることが確認された。
[Analysis of alkylresorcinol by high performance liquid chromatography]
The amount of alkylresorcinol in the dried product obtained in the preparation of the alkylresorcinol was determined by an analysis method using high performance liquid chromatography. In addition, hereinafter, alkylresorcinol may be referred to as "ARs" or "AR".
Specifically, Inertsil ODS4 manufactured by GL science was used as the analytical column, and the analytical conditions were a flow rate of 1 mL/min, a detection wavelength of 275 nm, a column temperature of 40°C, and a mobile phase (89 v/v% methanol → (5 (25 minutes) → 92 v/v% methanol → (25 minutes) → 100% methanol gradient). As a standard alkylresorcinol, commercially available olivetol (AR having a linear alkyl chain with 5 carbon atoms: Sigma-Aldrich) was used. For the quantification of ARs with different alkyl chain lengths than olivetol, the elution position is specified in advance, and for the actually measured peak area, the value obtained by dividing each molecular weight by the molecular weight of olivetol is used as a coefficient, and multiplied by that coefficient. Therefore, it was converted.
As a result, it was confirmed that 1 g of the ethanol extract obtained in the above preparation contained 35 mg of ARs.
[アルキルレゾルシノール摂取による便通改善]
上記エタノール抽出物を配合したクラッカーを、クラッカー1枚当たり約36mgのARsを含有するように製造した。また、プラセボとしてショートニングを上記エタノール抽出物と同量でクラッカーの原料に配合したプラセボクラッカーを製造した。BMIが23以上の男女38名が、ARs含有クラッカー又はプラセボクラッカー2枚ずつを40日間喫食し、当該ARs含有クラッカー又はプラセボクラッカー喫食実験前、実験中、及び実験後の排便回数(図1)と便性状(図2)を調査した。図2に示されたtype 4を4点、type 3とtype 5を3点、type 2とtype 6を2点、type 1とtype 7を1点として便性状の平均点を計算した。type 1~7の便の説明を図3に示す。なお、図1中、「*」は危険率p<0.05で有意差があることを示し、「**」は危険率p<0.01で有意差があることを示す。
[Improvement of bowel movements by taking alkylresorcinol]
Crackers containing the above ethanol extract were manufactured to contain about 36 mg of ARs per cracker. In addition, as a placebo, a placebo cracker was produced in which the same amount of shortening as the above-mentioned ethanol extract was blended into the cracker raw material. Thirty-eight men and women with a BMI of 23 or higher ate two ARs-containing crackers or two placebo crackers for 40 days, and compared the number of defecations before, during, and after the experiment with eating the ARs-containing crackers or placebo crackers (Figure 1). The stool properties (Figure 2) were investigated. The average score for stool quality was calculated by assigning 4 points to type 4 shown in Figure 2, 3 points to type 3 and type 5, 2 points to type 2 and type 6, and 1 point to type 1 and type 7. Figure 3 shows an explanation of types 1 to 7 flights. In FIG. 1, "*" indicates that there is a significant difference when the risk rate p<0.05, and "**" indicates that there is a significant difference when the risk rate p<0.01.
ARs含有クラッカーの喫食により、排便回数が増加し、便性状は向上した。さらに実験終了後もその効果は維持されていた。上記結果から、ARsの摂取による便通改善が確認された。 Eating ARs-containing crackers increased the frequency of defecation and improved stool quality. Furthermore, the effect was maintained even after the experiment ended. From the above results, it was confirmed that ingestion of ARs improved defecation.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022046599A JP2023140651A (en) | 2022-03-23 | 2022-03-23 | Bowel movement improving composition, method for producing bowel movement improving composition, and method for improving bowel movement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022046599A JP2023140651A (en) | 2022-03-23 | 2022-03-23 | Bowel movement improving composition, method for producing bowel movement improving composition, and method for improving bowel movement |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023140651A true JP2023140651A (en) | 2023-10-05 |
Family
ID=88206433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022046599A Pending JP2023140651A (en) | 2022-03-23 | 2022-03-23 | Bowel movement improving composition, method for producing bowel movement improving composition, and method for improving bowel movement |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023140651A (en) |
-
2022
- 2022-03-23 JP JP2022046599A patent/JP2023140651A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6818018B2 (en) | Composition for prevention, improvement or treatment of muscle diseases or improvement of muscle function | |
KR100740564B1 (en) | A oil composition enriched in diglyceride with conjugated linoleic acid | |
JP5334492B2 (en) | High concentration astaxanthin extract | |
TW200407080A (en) | Fat composition | |
CA2478934A1 (en) | Process for producing oil and fat composition containing hydrophobic components of glycyrrhiza | |
JP6241000B2 (en) | Glucose tolerance improving agent | |
WO2018065479A1 (en) | Chicory products containing cannabinoids | |
JP5261808B2 (en) | Fat accumulation inhibitor, medicine and method for newly imparting fat accumulation inhibitory action | |
JP7333815B2 (en) | COMPOSITION FOR IMPROVING LIVER FUNCTION | |
CA2525486C (en) | Composition for lowering the internal lipid | |
KR20060119706A (en) | Processed fat composition for preventing/ameliorating lifestyle-related diseases | |
WO2015193962A1 (en) | Agent for improving glucose tolerance disorder | |
TWI277422B (en) | Turmeric-containing composition | |
JP2013249260A (en) | Senescence retardant | |
JP2023140651A (en) | Bowel movement improving composition, method for producing bowel movement improving composition, and method for improving bowel movement | |
JP4191420B2 (en) | Edible oil and fat composition comprising a licorice hydrophobic extract | |
JP4268473B2 (en) | Oil composition | |
JP2007070263A (en) | Composition for preventing diabetes mellitus | |
JP2010126489A (en) | Lipase inhibitor and anti-obesity agent | |
JP2007070265A (en) | Composition for improving lipid metabolism | |
JPWO2004064830A1 (en) | Oil processing composition for prevention and improvement of lifestyle-related diseases | |
JP7239135B2 (en) | α-Glucosidase activity inhibitor and blood sugar elevation inhibitor | |
JP2012158528A (en) | IgE AND IL-4 PRODUCTION INHIBITION COMPOSITION | |
JP2002316940A (en) | Colon cancer-preventing agent | |
JP2004002544A (en) | Antioxidant |